Healthcare professionals should maintain awareness of patient-reported symptoms whilst recognising the complex relationship between GLP-1 agonists, their therapeutic effects, and joint symptoms
These mechanisms together maintain the steady-state level of carnitine in the human body, thereby supporting fatty acid oxidation and energy metabolism
GLP-1 drugs have been used by large shares of adults who say they have been diagnosed with diabetes (57% have ever used the drug, including 45% who are currently using), heart disease (40% ever, 29% currently), or as obese or overweight in the past five years (34% ever, 23% currently)
Nakamura K, Hayama A, Masada M, Fukushima K, Tamura G (1987) Measurement of serine acetyltransferase activity in crude plant-extracts by a coupled assay system using cysteine synthase
2007 marzo
D., Hume, D